Transitional cell carcinoma of the ovary

Journal of the Chinese Medical Association

Volumn 74, Issue 10, 2011, Pages 478-479

  Li, Yiu Tai ^a   Su, Wen Hsiang ^b,c   Lee, Wen Ling ^b,d  

^a KUO GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^c Yee Zen Hospital   (Taiwan)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; GEMCITABINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; OUTCOME ASSESSMENT; OVARY CARCINOMA; PROGNOSIS; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA OF THE OVARY;

CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; OVARIAN NEOPLASMS;

EID: 80955145688     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.08.021     Document Type: Letter

References (4)

1. Yu C.C., Chen S.L., Lian J.D., Koo C.L., Shih Y.T. Primary ovary transitional cell carcinoma after renal transplantation. J Chin Med Assoc 2011, 74:230-232.
2. Lin C.H., Liu F.S., Ho E.S. Transitional cell carcinoma of the ovary. Taiwan J Obstet Gynecol 2006, 45:268-271.
3. Kommoss F., Kommoss S., Schmidt D., Trunk M.J., Pfisterer J., du Bois A. Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecol Oncol 2005, 97:195-199.
4. Shelley M., Cleves A., Wilt T.J., Mason M. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. Cochrane Database Syst Rev 2011, 4:CD008976.